12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Themis Bioscience preclinical data

Themis said its dengue fever vaccine was "effective" against all 4 serotypes of dengue virus in vivo. The vaccine...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >